Sorry!! The article you are trying to read is not available now.
UPDATE 1-Novartis wins EU okay for first meningitis B vaccine
LONDON, Nov 16 (Reuters) - The first vaccine against meningitis B has been recommended for approval in Europe in a boost for its maker Novartis, which has struggled in the vaccines field against larger rivals.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here